http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111297856-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-233 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-233 |
| filingDate | 2020-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111297856-B |
| titleOfInvention | Medicinal composition for resisting fungal infection and application thereof |
| abstract | The invention belongs to the technical field of medicines, and particularly relates to a pharmaceutical composition for resisting fungal infection and application thereof. The alkaloid compound of the formula (I) has the application of resisting fungal infection, and provides a new candidate medicament for treating fungal infection. In addition, the invention also discovers that the compound shown in the formula (I) and the itraconazole are used together through a drug combination experiment, so that the compound has a synergistic antifungal effect, the dosage of active ingredients of the drug is reduced, and meanwhile, the drug resistance of microorganisms and side effects of a human body can be reduced, and a foundation is laid for the screening research of novel antifungal drugs. |
| priorityDate | 2020-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 72.